Viral and host factors in early hepatitis C virus infection

Hepatology

Volumn 42, Issue 1, 2005, Pages 86-92

  Mosley, James W ^a,f   Operskalski, Eva A ^a   Tobler, Leslie H ^b   Andrews, William W ^c   Phelps, Bruce ^c   Dockter, Janel ^d   Giachetti, Cristina ^b   Busch, Michael P ^b,e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d Gen Probe Incorporated   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ACUTE HEPATITIS; ADULT; ARTICLE; BLOOD TRANSFUSION; EARLY DIAGNOSIS; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; VIREMIA; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; RNA, VIRAL; VIRAL LOAD;

EID: 21344435943     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20742     Document Type: Article

References (26)

1. Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed. Blood Safety in the New Millennium. Bethesda: American Association of Blood Banks, 2001:33-54.
2. Seeff LB, Hollinger FB, Alter HJ, Wright EC, Cain CM, Buskell ZJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung and Blood Institute collaborative study. HEPATOLOGY 2001;33:455-463.
3. Mosley JW, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, et al. Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA 1990;263:777-781.
4. Mimms LT, Mosley JW, Hollinger FB, Aach RD, Stevens CE, Cunningham M, et al. Transfusion-transmitted co-infection with human hepatitis B and hepatitis C viruses. BMJ 1993;307:1095-1097.
5. Mosley JW, Huang W, Stram DO, Nowicki MJ, Hollinger FB, Aach RD, et al. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes. Transfusion 1996;36:776-781.
6. Lin HJ, Seeff LB, Barbosa L, Hollinger FB. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time. HEPATOLOGY 2001;34:424-429.
7. Operskalski EA, Mosley JW, Tobler LH, Fiebig EW, Nowicki MJ, Mimms LT, et al. HCV viral load in anti-HCV-reactive donors and infectivity for their recipients. Transfusion 2003;43:1433-1441.
8. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the Transfusion-Transmitted Viruses Study. N Engl J Med 1981;304:989-994.
9. Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984;101:733-738.
10. Hollinger FB, Mosley JW, Szmuness W, Aach RD, Melnick JL, Afifi A, et al. Non-A, non-B hepatitis following blood transfusion: risk factors associated with donor characteristics. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral Hepatitis; 1981 International Symposium. Philadelphia: Franklin Institute Press, 1982:361-376.
11. Mosley JW, Goodwin RG. Stability of serum glutamic pyruvic transaminase activity on storage. Am J Clin Pathol 1965;44:591-595.
12. Giachetti C, Linnen J, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, et al. Highly sensitive multiplex assay for detection of HIV-1 and HCV RNA. J Clin Microbiol 2002;40:1761-1766.
13. JM Last, ed. A Dictionary of Epidemiology. New York: Oxford University Press, 1983: 49.
14. Esteban JI, Cordoba J, Sauleda S. The clinical picture of acute and chronic hepatitis C. In: Reesink HW, ed. Hepatitis C Virus. 2nd ed. Basel: Karger, 1998:102-118.
15. Prince AM, Brotman B, Grady GF, Kuhns WJ, Hazzi C, Levine RW, et al. Long-incubation post-transfusion hepatitis without serological evidence of exposure the hepatitis-B virus. Lancet 1974;2:241-246.
16. Alter HJ, Holland PV, Morrow AG, Purcell RH, Feinstone SM, Moritsugu Y. Clinical and serological analysis of transfusion-associate hepatitis. Lancet 1975;2:838-841.
17. Seeff LB, Wright EC, Zimmerman HJ, McCollum RW. VA cooperative study of post-transfusion hepatitis, 1969-1974: incidence and characteristics of hepatitis and responsible risk factors. Am J Med Sci 1975;270:355-362.
18. Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000;132:105-111.
19. Dockter J, Schneider W, Cox D, Millar C, McDonough S, Giachetti C. Long term stability of HIV-1 and HCV specimens collected in different anticoagulants and stored at -20°C or -70°C. Transfusion 2003; 41(Suppl):121A-122A.
20. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci 2002;99:15661-15668.
21. Thimme R, Oldach D, Chang K-M, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Emerg Med 2001;194:1395-1406.
22. Roizman B, Palese P. Multiplication of viruses: an overview. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3rd ed. Philadelphia, Lippincott-Raven, 1996:102.
23. Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. HEPATOLOGY 2002;35:680-687.
24. Glynn SA, Wright DJ, Kleinman SH, Hirschkorn H, Tu Y, Heldebrant C, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion (in press).
25. Huang S-J, Lee S-D, Lu R-H, Chu CW, Wu JC, Lai S-T, et al. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol 2001;65:505-509.
26. Santantonio T, Sinisi E, Guastadisegni A, Casalino C, Mazzola M, Gentile A, et al. Natural course of acute hepatitis C: a long-term prospective study. Dig Liver Dis 2003;35:104-113.